Tailored Interventions to Improve Medication Adherence for Cardiovascular Diseases

被引:32
作者
Xu, Hai-Yan [1 ]
Yu, Yong-Ju [2 ]
Zhang, Qian-Hui [3 ]
Hu, Hou-Yuan [4 ]
Li, Min [1 ]
机构
[1] Army Med Univ, Sch Psychol, Dept Mil Psychol, Chongqing, Peoples R China
[2] Sichuan Int Studies Univ, Sch Sociol & Law, Dept Social Work, Chongqing, Peoples R China
[3] Army Med Univ, Sch Basic Med, Dept Foreign Languages, Chongqing, Peoples R China
[4] Army Med Univ, Southwest Hosp, Dept Cardiol, Chongqing, Peoples R China
来源
FRONTIERS IN PHARMACOLOGY | 2020年 / 11卷
关键词
medication adherence; medication adherence interventions; tailored interventions; barriers to medication adherence; cardiovascular disease; ACUTE CORONARY SYNDROME; MYOCARDIAL-INFARCTION; BARRIERS; NONADHERENCE; PREDICTORS; FRAMEWORK; LESSONS; SCIENCE; TRIALS;
D O I
10.3389/fphar.2020.510339
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past half-century, medical research on cardiovascular disease (CVD) has achieved a great deal; however, medication adherence is unsatisfactory. Nearly 50% of patients do not follow prescriptions when taking medications, which limits the ability to maximize their therapeutic effects and results in adverse clinical outcomes and high healthcare costs. Furthermore, the effects of medication adherence interventions are disappointing, and tailored interventions have been proposed as an appropriate way to improve medication adherence. To rethink and reconstruct methods of improving medication adherence for CVD, the literature on tailored interventions for medication adherence focusing on CVD within the last 5 years is retrieved and reviewed. Focusing on identifying nonadherent patients, detecting barriers to medication adherence, delivering clinical interventions, and constructing theories, this article reviews the present state of tailored interventions for medication adherence in CVD and also rethinks the present difficulties and suggests avenues for future development.
引用
收藏
页数:10
相关论文
共 64 条
  • [1] Targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: study protocol of a cluster randomised controlled trial
    Alfian, Sofa D.
    Abdulah, Rizky
    Denig, Petra
    van Boven, Job F. M.
    Hak, Eelko
    [J]. BMJ OPEN, 2020, 10 (01):
  • [2] Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials from a Cochrane systematic review
    Allemann, Samuel S.
    Nieuwlaat, Robby
    Navarro, Tamara
    Haynes, Brian
    Hersbergera, Kurt E.
    Arnet, Isabelle
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017, 91 : 70 - 79
  • [3] Matching Adherence Interventions to Patient Determinants Using the Theoretical Domains Framework
    Allemann, Samuel S.
    Nieuwlaat, Robby
    van den Bemt, Bart J. f
    Hersberger, Kurt E.
    Arnet, Isabelle
    [J]. FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [4] [Anonymous], 2003, Adherence to Long-Term Therapies: Evidence for action
  • [5] Searching for Adherence Can We Fulfill the Promise of Evidence-Based Medicines?
    Armstrong, Paul W.
    McAlister, Finlay A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (08) : 802 - 804
  • [6] Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes
    Baker, Richard
    Camosso-Stefinovic, Janette
    Gillies, Clare
    Shaw, Elizabeth J.
    Cheater, Francine
    Flottorp, Signe
    Robertson, Noelle
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (03):
  • [7] Health system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic review
    Banerjee, Amitava
    Khandelwal, Shweta
    Nambiar, Lavanya
    Saxena, Malvika
    Peck, Victoria
    Moniruzzaman, Mohammed
    Faria Neto, Jose Rocha
    Quinto, Katherine Curi
    Smyth, Andrew
    Leong, Darryl
    Werba, Jose Pablo
    [J]. OPEN HEART, 2016, 3 (02):
  • [8] Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes
    Bansilal, Sameer
    Maria Castellano, Jose
    Garrido, Ester
    Wei, Henry G.
    Freeman, Allison
    Spettell, Claire
    Garcia-Alonso, Fernando
    Lizano, Irene
    Arnold, Renee J. G.
    Rajda, Jay
    Steinberg, Gregory
    Fuster, Valentin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (08) : 789 - 801
  • [9] A Systematic Review of Medication Adherence Thresholds Dependent of Clinical Outcomes
    Baumgartner, Pascal C.
    Haynes, R. Brian
    Hersberger, Kurt E.
    Arnet, Isabelle
    [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [10] The Cost-Effectiveness of an Intervention Program to Enhance Adherence to Antihypertensive Medication in Comparison With Usual Care in Community Pharmacies
    Bosmans, Judith E.
    van der Laan, Danielle M.
    Yang, Yuanhang
    Elders, Petra J. M.
    Boons, Christel C. L. M.
    Nijpels, Giel
    Hugtenburg, Jacqueline G.
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10